Surgery Websites
Department of Surgery »  Faculty »  General Surgery »  Kimberly Kirkwood, M.D.
Kimberly Kirkwood, M.D.

Kimberly Kirkwood, M.D.

Professor of Surgery
Division of General Surgery

Contact Information

(415) 514-1964
(415) 476-8694 Fax
Open Popup
  • B.A., Reed College, 1981
  • M.D., University of Pennsylvania,  1985
  • Massachusetts General Hospital, Resident, Surgery, 1986-88
  • Massachusetts General Hospital, Resident, Surgery, 1991-92
  • Massachusetts General Hospital, Chief Resident, Surgery, 1992-93
  • University of California, Los Angeles, Postdoctoral Fellow, Gastrointestinal Physiology, 1988-91
  • American Board of Surgery, 1994, recertified 2014
  • Benign Pancreatic Lesions
  • Biliary Tract Surgery
  • Gallbladder Surgery
  • Pancreatic Cancer
  • Stomach and Gastrointestinal Surgery

Dr. Kimberly Kirkwood specializes in the treatment of pancreatic cancer as well as tumors of the stomach, spleen, gallbladder, bile duct and gastrointestinal tract. A skillful laparoscopic surgeon, she is an expert in applying minimally invasive techniques to treat abdominal tumors and has a particular interest in improving outcomes for patients after pancreas surgery.  Dr. Kirkwood is a member of the UCSF Helen Diller Family Comprehensive Cancer Center and Participates in Cancer Center Clinical Trials.

Dr. Kirkwood earned a medical degree at the University of Pennsylvania and completed a surgical residency and a fellowship in advanced general surgery with a focus on pancreatic surgery at Massachusetts General Hospital. She also completed a three-year surgical research fellowship at UCLA in hepatobiliary disease. Dr. Kirkwood is active in many national societies including the Pancreas Club, Society for Surgery of the Alimentary Tract, Association for Academic Surgeons and she is on the Executive Council of the Society of University Surgeons. Her NIH-funded research focuses on pancreatic inflammatory pain and on the many factors which may improve outcomes for patients following resection of pancreatic tumors. 

  • Excellence in Teaching Award, Inaugural, UCSF Department of Surgery Junior Residents, 2015
  • Excellence in Teaching Award, UCSF Department of Surgery Chief Residents, 2014
  • Excellence in Teaching Award, UCSF School of Medicine, Surgical Clerkship, 2013
  • Excellence in Teaching Award, UCSF Department of Surgery Chief Residents, 2012
  • AGA Student Abstract Prize (Victoria Lyo),, American Gastroenterological Association (AGA) Foundation, 2010
  • Howard Hughes Research Fellowship (Victoria Lyo),, Howard Hughes Medical Institute, 2010
  • Pancreas Club Warren Award (Victoria Lyo),, Pancreas Club, 2010
  • Kaiser Award for Excellence in Teaching Nomination, UCSF School of Medicine, 2010
  • Excellence in Teaching Award, UCSF Department of Surgery Chief Residents, 2008-2009
  • Excellence in Teaching Award, UCSF Department of Surgery Chief Residents, 2004
  • Kaiser Award for Excellence in Teaching Nomination, UCSF School of Medicine, 2004
  • Excellence in Teaching Award, UCSF Department of Surgery Residents, 2001
  • Kaiser Award for Excellence in Teaching Nomination, UCSF School of Medicine, 1999
  • Kaiser Award for Excellence in Teaching Nomination, UCSF School of Medicine, 1997
  • Claude E. Welch Research Fellowship Award, Department of Surgery, Massachusetts General Hospita, 1989-1990
  • President, Alpha Omega Alpha National Medical Honor Society, University of Pennsylvania Chapter, 1983
  • Phi Beta Kappa National Honor Society, Phi Beta Kappa National Honor Society, 1981
  • Walter Croll Scholarship, University of Pennsylvania School of Medicine, 1981
View all
  • NIH R21 " Non-invasive Differentiation of Benign Lesions from Aggressive Pancreatic Cancer".This arises from a new collaboration with Charles Craik, Professor in Pharmaceutical Chemistry
  • U01 CA196403-01 Maitra (PI) 11/01/2015-08/31/2020, NIH The Development of Targeted Therapeutic Approaches for Pancreatic Cancer, (Objective is to identify molecular and imaging parameters that predict either synchronous malignancy or reliably predict the potential for progression in pancreatic cystic lesions, Role: PI Maitra; Kirkwood, Site Director
  • R21 CA185962 Sen (PI) 01/01/2016-12/31/201, NIH Pancreatic Cyst Fluid miRNome for Biomarkers of Pancreatic Cancer, (Objective is to examine differentially expressed cyst fluid and blood plasma miRNA biomarker signatures in low grade versus high grade IPMNs), Role: Co-Investigator
Most recent publications from a total of 38
  1. Changala M, Laberge J, Kerlan R, Taylor A, Arain M, Kirkwood K. Managing Refractory Postoperative Fistulas as Chronic Wounds Using Video-Assisted Hydrodebridement (VAHD). J Gastrointest Surg. 2018 Nov 21. View in PubMed
  2. Kim SS, Ko AH, Nakakura EK, Wang ZJ, Corvera CU, Harris HW, Kirkwood KS, Hirose R, Tempero MA, Kim GE. Comparison of Tumor Regression Grading of Residual Pancreatic Ductal Adenocarcinoma Following Neoadjuvant Chemotherapy Without Radiation: Would Fewer Tier-Stratification Be Favorable Toward Standardization? Am J Surg Pathol. 2018 Sep 11. View in PubMed
  3. Sharib JM, Fonseca AL, Swords DS, Jaradeh K, Bracci PM, Firpo MA, Hatcher S, Scaife CL, Wang H, Kim GE, Mulvihill SJ, Maitra A, Koay EJ, Kirkwood KS. Surgical overtreatment of pancreatic intraductal papillary mucinous neoplasms: Do the 2017 International Consensus Guidelines improve clinical decision making? Surgery. 2018 Dec; 164(6):1178-1184. View in PubMed
  4. Fonseca AL, Kirkwood K, Kim MP, Maitra A, Koay EJ. Intraductal Papillary Mucinous Neoplasms of the Pancreas: Current Understanding and Future Directions for Stratification of Malignancy Risk. Pancreas. 2018 03; 47(3):272-279. View in PubMed
  5. Kirkwood R, Damon L, Wang J, Hong E, Kirkwood K. Gangrenous cholecystitis: innovative laparoscopic techniques to facilitate subtotal fenestrating cholecystectomy when a critical view of safety cannot be achieved. Surg Endosc. 2017 12; 31(12):5258-5266. View in PubMed
  6. Ivry SL, Sharib JM, Dominguez DA, Roy N, Hatcher SE, Yip-Schneider MT, Schmidt CM, Brand RE, Park WG, Hebrok M, Kim GE, O'Donoghue AJ, Kirkwood KS, Craik CS. Global Protease Activity Profiling Provides Differential Diagnosis of Pancreatic Cysts. Clin Cancer Res. 2017 Aug 15; 23(16):4865-4874. View in PubMed
  7. Sharib J, Kirkwood K. Early and accurate diagnosis of pancreatic cancer? Oncotarget. 2016 12 27; 7(52):85676-85677. View in PubMed
  8. Kim SS, Nakakura EK, Wang ZJ, Kim GE, Corvera CU, Harris HW, Kirkwood KS, Hirose R, Tempero MA, Ko AH. Preoperative FOLFIRINOX for borderline resectable pancreatic cancer: Is radiation necessary in the modern era of chemotherapy? J Surg Oncol. 2016 Oct; 114(5):587-596. View in PubMed
  9. Wang J, Paris PL, Chen J, Ngo V, Yao H, Frazier ML, Killary AM, Liu CG, Liang H, Mathy C, Bondada S, Kirkwood K, Sen S. Next generation sequencing of pancreatic cyst fluid microRNAs from low grade-benign and high grade-invasive lesions. Cancer Lett. 2015 Jan 28; 356(2 Pt B):404-9. View in PubMed
  10. Cattaruzza F, Amadesi S, Carlsson JF, Murphy JE, Lyo V, Kirkwood K, Cottrell GS, Bogyo M, Knecht W, Bunnett NW. Serine proteases and protease-activated receptor 2 mediate the proinflammatory and algesic actions of diverse stimulants. Br J Pharmacol. 2014 Aug; 171(16):3814-26. View in PubMed
  11. View All Publications
Publications provided by UCSF Profiles, powered by CTSI at UCSF. View profile of Kimberly Kirkwood, M.D.
Please note: UCSF Profiles publications are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact CTSI for help.

Site Directory